Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK55718 for Postoperative Pain Treatment in Orthopedic Surgery
NCT07551739Phase 2Not yet recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of HSK55718 in postoperative pain (5 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Sum of Pain Intensity Differences at 48 hours. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
HSK55718
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07551739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07551739.